retatrutide vs orforglipron PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Orforglipron vs Retatrutide: Efficacy, Safety
Description
All confidence intervals indicated statistically significant associations ( Figure 5 )

Patients should be advised that they may not have glycemic improvement for 24 weeks after initiating treatment with long-acting GLP-1 receptor agonists

Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS: Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study

The 1ml option works well for experienced users who need smaller injection volumes or are on higher doses

The American Academy of Pediatrics and major obstetric societies suggest delaying GLP-1 initiation or considering alternatives during active breastfeeding

How GLP-1 Medications Work Without Exercise: The Appetite and Metabolism Connection GLP-1 receptor agonists (like semaglutide and tirzepatide) suppress hunger signals in the brain's hypothalamus, reduce gastric emptying, and increase feelings of fullnessall of which can lower calorie intake without physical activity
